Dasatinib Tablets

Dasatinib Tablets Specification

Dosage Form
Tablet

Indication
Treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL)

Salt Composition
Dasatinib

Feature
Orally active, potent tyrosine kinase inhibitor

Ingredients
Dasatinib Monohydrate, Excipients

Application
Oncology Cancer treatment

Physical Color/Texture
White to off-white, film-coated tablets

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 months

About Dasatinib Tablets

Dasatinib Tablets stand as an elite and trending choice in oncology therapy, renowned for their exceptional efficacy in the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). With strengths available in 20 mg, 50 mg, 70 mg, and 100 mg, each bottle contains 30 flawless tablets, clearly embossed for dosage accuracy. Rapid absorption and high oral bioavailability ensure unprecedented therapeutic impact, supported by FDA and EMA approvals. In demand globally, these potent tyrosine kinase inhibitors offer prescription-only excellence for adult patients worldwide, reflecting their trusted status among healthcare professionals.

Unprecedented Cancer Care Application

Dasatinib Tablets are primarily intended for adult patients diagnosed with CML or ALL. Their use type is strictly oral, with administration typically once daily or as advised by a physician. Extra features include potent tyrosine kinase inhibition and clear tablet markings for dosage verification. These elite tablets ensure safety with comprehensive contraindications and precautions, especially in those with hepatic impairment, pregnancy, or lactation. Ideal for oncological settings, they deliver exceptional treatment benefits for eligible users.

Dedicated Worldwide Supply & Export Readiness

Dasatinib Tablets are stock ready with timely order completion for dealers, distributors, exporters, suppliers, traders, and wholesalers, particularly in India. Our main export markets span multiple countries worldwide, reflecting high demand. Competitive rates are offered for bulk procurement, and supply is coordinated from a designated FOB port for international shipments. Compliance with regulatory standards and robust packaging ensures seamless delivery and preservation of tablet quality from dispatch to receipt.

FAQs of Dasatinib Tablets:

Q: How should Dasatinib Tablets be administered for effective treatment?

A: Dasatinib Tablets are designed to be taken orally, usually once daily or as directed by your physician, ensuring optimal absorption and efficacy in the treatment of leukemia.

Q: What are the primary indications for prescribing Dasatinib Tablets?

A: These tablets are indicated for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) in adult patients, as per physicians guidance.

Q: When is Dasatinib contraindicated for use?

A: Dasatinib is contraindicated in individuals who have hypersensitivity to Dasatinib or any of its excipients, and caution is required in cases of hepatic impairment, pregnancy, or during lactation.

Q: Where are Dasatinib Tablets available for purchase and export?

A: Dasatinib Tablets are available across multiple countries worldwide, with strong stock readiness and export capabilities, especially from India for dealers and wholesalers.

Q: What benefits does rapid Dasatinib absorption provide to patients?

A: Rapid absorption after oral administration ensures high bioavailability, leading to efficient delivery of the active ingredient for swift therapeutic action against leukemia.

Q: How does the ordering process for Dasatinib Tablets ensure timely completion?

A: Orders for Dasatinib Tablets are processed promptly, with stock ready for dispatch and completion coordinated through an established FOB port to maintain supply reliability.

Get Latest Price